HIV/AIDS and Drug Abuse Prevention Campaign in the Workplace: Partnership of PT Unilever Indonesia Tbk and KKI
2010 | Download
PT Unilever Indonesia Tbk (UI) and The Indonesian Humanitarian Committee (Komite Kemanusiaan Indonesia or KKI) have partnered since 2003 to prevent HIV and drug abuse among workers at a UI factory in Cikarang, an industrial area just outside of Jakarta. Most of the workers are men. The core of the partnership is a training-of-trainers (TOT) program carried out by KKI to create a team of volunteer workers who then provide information and training to other workers on behavior changes needed to prevent HIV/AIDS and drug abuse.
Team ANHA (Anti-Drugs or “Narkoba” and HIV/AIDS) operates under the coordination of the head of Occupational Health Services (OHS) at the factory. Since 2004, KKI has conducted three TOT courses that have produced 62 team members who include not only Unilever employees, but workers from other companies in the same industrial area, including suppliers of UI.
Team members also provide prevention information to surrounding communities and schools. Activities in Indonesia led to a change in Unilever Indonesia company policy towards HIV/AIDS prevention and drug abuse in the workplace signed and issued by the chairman of Unilever worldwide in January 2007.
Since 2004, Team ANHA members have reached 2,000 workers in the UI Cikarang factory and another 2,000 workers among Unilever suppliers. They have also reached students in six schools and people from 14 nearby neighborhoods. In 2011, UI and KKI plan to convene a fourth TOT to include workers from neighboring factories including those of Mattel, Kimberly Clark, and Mulia Ceramics.
ABOUT THIS CASE STUDY
This is one in a series of case studies based on presentations by partners at sessions of the Health and Business Roundtable Indonesia (HBRI). HBRI is an activity of Company-Community Partnerships for Health in Indonesia (CCPHI), a project of the Public Health Institute funded by the Ford Foundation. This case study is based on presentations made by Oyo Zakaria, Secretary Komite Kemanusiaan Indonesia and Dr. Johny Sulistio, Senior Medical Advisor for PT Unilever Indonesia, at the 7 th session of the Health and Business Roundtable Indonesia (HBRI). CCPHI staff members prepared the study in consultation with UI and KKI.